NEW YORK (AP) — Generic drugmaker Mylan is making official its offer for over-the-counter medicines maker Perrigo despite opposition from a larger rival that wants to buy Mylan. By buying Perrigo, Mylan hopes to create a company with more than $15 billion in annual sales of specialty and generic drugs, over-the-counter-products, infant formula and vitamins.Read more on NewsOK.com

Sections:  news   business   
BING NEWS:
  • Zydus launches generic Myrbetriq
    Mirabegron is indicated for the treatment of overactive bladder with symptoms relating to urgency and urinary frequency.
    04/23/2024 - 2:20 am | View Link
  • Drug maker Lupin launches Mirabegron extended-release tablets in US market
    The Mumbai-based drug maker Lupin has introduced the medication after receiving an approval from the US Food and Drug Administration (USFDA), Lupin said in a statement.
    04/21/2024 - 8:04 pm | View Link
  • Biocon leads generic race for blockbuster weight loss drugs as patents set to expire soon
    Both Ozempic and Wegovy by Novo Nordisk are made with the same active ingredient, semaglutide, while Eli Lilly’s tirzepatide drug is sold as Zepbound.
    04/7/2024 - 6:21 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News